However, biomarkers should not to be used alone for outcome prediction, and the only biomarker recommended to be included in the multimodal approach for prognostication by current guidelines on postresuscitation care is NSE, a marker of CNS tissue destruction having acceptable prognostic value 48 h after cardiac arrest.2 Here, ENO2 is linked to cardiac arrest.